Showing results (201-210 of 218) with videos related to

Sort By:
Pageof 22
Hepatology (Baltimore, Md.)|January 1, 1995
Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and CirrhosisG Fattovich, G Giustina, S W Schalm, et al.
Scandinavian Journal of Gastroenterology|May 1, 1983
Oral testosterone load related to liver function in men with alcoholic liver cirrhosisC Gluud, M Bahnsen, P Bennett, et al.
Journal of Hepatology|May 1, 1990
Branched chain enriched amino acid versus glucose treatment of hepatic encephalopathy. A double-blind study of 65 patients with cirrhosisH Vilstrup, C Gluud, F Hardt, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire). Supplement|January 1, 1991
An international study of the relationship between alcohol consumption and postmenopausal estradiol levelsJ S Gavaler, K Love, D Van Thiel, et al.
Scandinavian Journal of Gastroenterology|October 1, 1983
Hypothalamic-pituitary-gonadal function in relation to liver function in men with alcoholic cirrhosisC Gluud, M Bahnsen, P Bennett, et al.
Gut|February 1, 1990
Acyclovir in the prevention of duodenal ulcer recurrenceS J Rune, J Linde, O Bonnevie, et al.
Alimentary Pharmacology & Therapeutics|October 11, 2017
Systematic review and meta-analysis: assessment of factors affecting disability in inflammatory bowel disease and the reliability of the inflammatory bowel disease disability indexB Lo, M V Prosberg, L L Gluud, et al.
Epidemiology and Psychiatric Sciences|October 23, 2024
The risks of adverse events with venlafaxine for adults with major depressive disorder: a systematic review of randomised clinical trials with meta-analysis and Trial Sequential AnalysisC B Kamp, J J Petersen, P Faltermeier, et al.
Ugeskrift for Laeger|October 15, 1998
[Pretreatment with prednisolone enhances the effect of human lymphoblastoid interferon in chronic hepatitis B]K Krogsgaard, P Marcellin, C Trepo, et al.
Journal of Hepatology|December 1, 1996
Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. INTERPRED Trial GroupK Krogsgaard, P Marcellin, C Trepo, et al.
Pageof 22